ResMed Inc. |
Market Cap (24-Aug) $46,348,267,520 (13th) |
Close (30-Jun) $32.81 |
Volume (30-Jun) 1,098,777 |
Shortsold (17-Aug) 3,152,203 (0.53%) (302nd) |
|
52w High $44.78 |
52w Low $25.42 |
P/E 18.94 |
EPS 1.47 |
[ARTICLE] Why the Ozempic revolution matters to ASX investors
A news article has been posted about ResMed Inc. on the AFR. The article was published around , on 7 September 2023 at 3:01pm.
The debate around the potential for weight loss drugs to hit sleep apnoea giant ResMed raises important questions for investors as they consider other big themes like artificial intelligence.
Read ArticleRMD was $32.81 at the close of trade on 30 June 2023
| Recent Articles about ASX:RMD | |
|---|---|
| 8-Aug | Notification of dividend / distribution Appendix 3A.1 - Market Index
company-announcements.afr.com |
| 7-Aug | ResMed ASX Deferral of Conversions Announcement - August 2026
company-announcements.afr.com |
| 7-Aug | Resmed Inc. Announces Results for the Fourth Quarter of Fiscal ...
company-announcements.afr.com |
| 7-Aug | DJW NTA - AFR
company-announcements.afr.com |
| 31-Jul | 30 July 2026 The Manager ASX Market Announcements ASX ... - AFR
company-announcements.afr.com |
| 24-Jul | DJW Appendix 4E and media release 30 June 2026 - AFR
company-announcements.afr.com |
| 10-Jul | Australian United Investment Company Limited - AFR
company-announcements.afr.com |
| 8-Jul | ResMed Inc. - AFR
company-announcements.afr.com |
| 7-Jul | FORM 4 - AFR
company-announcements.afr.com |
| 3-Jul | AMH NTA - AFR
company-announcements.afr.com |
| Tracked |
Find all articles about ResMed Inc., including others on the AFR, on the media page.
You must be logged in to post a reply.